Startup profile for Heaviside Industries: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Heaviside Industries funding, valuation and investors

Autonomous precision munitions across air, land, and sea for U.S. and allied forces.

Keep track of Heaviside Industries

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$60M · August 2026

Latest known valuation

$600M

Series B · August 2026

Total disclosed equity funding

$88M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · Los Angeles, California

Investors in latest funding

Lead: Felicis

Other: Hedosophia , Menlo Ventures , Cantos

Sources: latest funding Last verified: 2026-08-18

Overview

Heaviside Industries, founded in 2024 by CEO Phillip Walker, builds autonomous precision munitions platforms for GPS-denied and jammed environments. Headquarters are Los Angeles, with additional offices in Oslo. On August 12, 2026 the company announced a $60 million Series B at a $600 million valuation, led by Felicis with significant participation from Hedosophia and additional participation from Menlo Ventures, Cantos, Flume Ventures, Qstar Capital, Friends & Family Capital, Anorak Ventures, MVP Ventures, and others. The same day it announced Nammo as warhead/payload supplier. The May 2026 $28 million Series A (out of stealth) is now a prior round; Tech Funding News attributes that lead to Interlagos, while the Series B PR does not restate it. Revenue, named customers, and contract values were not disclosed. The company says proceeds fund production, hiring, existing customer commitments, and a larger U.S. footprint. Press cites about $88 million raised in total.

Why Heaviside Industries is interesting

Three months after a $28M stealth Series A, Felicis led a $60M Series B at $600M (Aug 12, 2026) and Nammo will supply warheads — a manufacturing-and-supply bet, not a disclosed-revenue print.

Product & use cases

Multi-domain autonomous precision munitions platforms for U.S. and allied forces, designed for jammed and GPS-denied environments, with Nammo as the announced warhead supplier.

  • Precision strike in GPS-denied or jammed theaters
  • Unmanned munitions across air, land, and sea
  • Allied munitions supply using an established European warhead OEM

Key facts

  • Series B (Aug 12, 2026): $60M at $600M, Felicis led; Hedosophia significant (company)
  • Nammo partnership: warhead/payload supply plus production and testing access (company + Felicis)
  • Series A (May 2026): $28M out of stealth; TFN attributes lead to Interlagos — not restated in the B PR
  • Directory funds returning: Menlo Ventures (/fund/menlo-ventures), Cantos (/fund/cantos)
  • Revenue, named customers, and unit volumes not disclosed; press cites ~$88M total raised

Funding history (newest first)

Investors in our directory

Funds linked from Heaviside Industries's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Felicis’s published thesis is sequencing: lock buyer access, volume manufacturing, and regulation together, using Nammo’s existing production and testing base instead of building a warhead line from scratch. That is a partner story, not disclosed backlog.

Heaviside is a two-year-old munitions specialist next to Neros’s drone scale story and Anduril’s platform mark. The public proof is a $600M valuation plus a Nammo supplier announcement. Named programs and unit economics were not disclosed, so underwriting is manufacturing-and-access, not a revenue multiple.

  • Neros Technologies adjacent

    Same-week LA-area manufacturer; attritable strike/interceptor drones at $2.5B (Aug 11) vs Heaviside munitions at $600M (Aug 12).

  • Anduril adjacent

    $61B multi-product defense platform; category ceiling, not a like-for-like munitions peer.

  • Legacy primes (RTX, Lockheed, Nammo as OEM) incumbent

    Primes already have munitions lines; Nammo is Heaviside’s announced supplier, not only a competitor.

Notable stories

  • Felicis (Aug 12, 2026) describes touring a Los Angeles facility with an underwater test tank and argues the real defense test is delivering tens of thousands of units, not a prototype.
  • Tech Funding News calls the $600M mark more than 21× the Series A price in three months — press math on price, not a company-published A post-money.

Industries

Defense Tech Deep Tech

Related funding articles

Venture Capital Tracker pieces that cover Heaviside Industries's financing or category context.

FAQs about Heaviside Industries

Practical answers founders, operators, and investors typically search for.

$600 million as of the August 12, 2026 $60 million Series B led by Felicis.
Autonomous precision munitions platforms across air, land, and sea for U.S. and allied forces.
Felicis led, with significant participation from Hedosophia. Menlo Ventures (/fund/menlo-ventures) and Cantos (/fund/cantos) returned. Other PR names: Flume, Qstar, Friends & Family Capital, Anorak, MVP Ventures.
$60 million Series B plus $28 million Series A. Press cites about $88 million total. Named-customer dollars were not disclosed.
Nammo will supply warheads/payloads and production/testing infrastructure. It is not a disclosed offtake value.
Neros: $250M Series C at $2.5B (Aug 11) for attritable drones, with named DoD customer classes. Heaviside: $60M at $600M (Aug 12) for munitions plus Nammo, with unnamed commitments.
The Series B PR does not restate it. Tech Funding News says Interlagos led the May $28 million round. Treat that as press-attributed.
No — private.
Los Angeles, California, with additional offices in Oslo, Norway (company).
Not disclosed.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.